Ted Breck

Ted Breck leads TOP’s business in life sciences structured investments for mid- and late-stage pharma pipeline assets, drug launches and drug royalty monetizations. Previously, Ted Breck led the effort at TPG-Axon Capital for three years. Prior to joining TPG-Axon in 2005, Ted Breck had two decades of experience in healthcare investment banking at Lehman Brothers in New York and subsequently, San Francisco, where he led the firm’s West Coast business in financing and merger and acquisition transactions for biopharma, medical device and healthcare services companies. Ted Breck received his B.A. at the University of California at Berkeley. Ted Breck is a member of the Advisory Council of the J. David Gladstone Institutes, an independent, non-profit biomedical research organization affiliated with the University of California, San Francisco.